London, United Kingdom

Simon Hawke

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: D-Gen Limited. Active years: 2009.


% Patents Active = 100.0



Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Simon Hawke: Innovator in Prion Research

Introduction

Simon Hawke is a notable inventor based in London, GB. He has made significant contributions to the field of prion research, focusing on innovative methods for treating prion diseases. His work has the potential to impact the medical community and improve patient outcomes.

Latest Patents

Hawke holds a patent related to prion inhibition. The invention pertains to the use of an agent, such as an antibody, capable of reacting with PrP to prevent prion replication in a subject. This invention is crucial for the treatment or prevention of prion infection and the associated neuropathology. Additionally, it includes methods for inhibiting prion replication and the development of antibodies for use in these methods. He has 1 patent to his name.

Career Highlights

Simon Hawke has established himself as a key figure in prion research. His work at D-Gen Limited has allowed him to explore innovative solutions to complex medical challenges. His dedication to advancing the understanding of prion diseases is evident in his research and patent contributions.

Collaborations

Hawke collaborates with John Collinge, a fellow researcher in the field. Their partnership enhances the potential for groundbreaking discoveries in prion research.

Conclusion

Simon Hawke's contributions to prion research through his innovative patent and collaboration with esteemed colleagues highlight his commitment to advancing medical science. His work is poised to make a significant impact on the treatment of prion diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…